Replimune Group, Inc.
For the period ended Mar 31, 2025. Filed May 22, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed May 22, 2025
REPL$22.26+3.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated statements of operations F-
CONSOLIDATED STATEMENTS OF OPERATIONS
| Year Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating expenses: | ||
| Research and development | $189,447 | $174,963 |
| Selling, general and administrative | 72,180 | 59,810 |
| Total operating expenses | 261,627 | 234,773 |
| Loss from operations | (261,627) | (234,773) |
| Other income (expense): | ||
| Research and development incentives | 1,773 | 1,920 |
| Investment income | 21,120 | 23,356 |
| Interest expense on finance lease liability | (2,118) | (2,163) |
| Interest expense on debt obligations | (5,775) | (4,497) |
| Other (expense) income | (202) | 771 |
| Total other income, net | 14,798 | 19,387 |
| Loss before income taxes | $(246,829) | $(215,386) |
| Income tax provision | 468 | 408 |
| Net loss | $(247,297) | $(215,794) |
| Net loss per common share, basic and diluted | $(3.07) | $(3.24) |
| Weighted average common shares outstanding, basic and diluted | 80,564,147 | 66,569,894 |
F - 5
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.